The hospital brings together expert bariatric surgeons, gastroenterologists, dietitians, and endocrinologists who work as a team to manage conditions like dumping syndrome effectively
Decreased appetite was also reported in 5% of patients taking semaglutide tablets Drug Interactions When initiating Ozempic , consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia Ozempic causes a delay of gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications
The GLP-1 market is globalizing, diversifying, and accelerating
Meet our doctors Last reviewed: 19 Jun 2026 Sources Mounjaro KwikPen 10mg solution for injection in pre-filled pen SmPC, emc [accessed 25 May 2026] Once-Weekly Semaglutide in Adults with Overweight or Obesity, The New England Journal of Medicine (NEJM) [accessed 25 May 2026] Ozempic SmPC, emc [accessed 25 May 2026] Rybelsus 3 mg, emc [accessed 25 May 2026] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, NEJM [accessed 25 May 2026]
Desiree Granados Quick Summary: Semaglutide and phentermine are weight-management medications with different mechanisms: semaglutide activates GLP-1 receptors to reduce appetite and improve glycemic control with sustained outcomes, while phentermine primarily acts as a stimulant to suppress appetite short-term